AREC — Arecor Therapeutics Share News
0.000.00%
- £36.75m
- £30.34m
- £4.57m
REG - Arecor Therapeutics - Trading and Funding Update
AnnouncementREG - Arecor Therapeutics - Posting of 2023 Annual Report and Notice of AGM
AnnouncementREG - Arecor Therapeutics - Grant of Options and PDMR Dealing
AnnouncementREG - Arecor Therapeutics - Arecor to host company and KOL webinar today
AnnouncementREG - Arecor Therapeutics - Positive headline results for AT278 clinical trial
AnnouncementREG - Arecor Therapeutics - Final results for 2023
AnnouncementREG - Arecor Therapeutics - Notice of Results
AnnouncementREG - Arecor Therapeutics - Arecor and Medtronic Diabetes collaboration
AnnouncementREG - Arecor Therapeutics - Publication of Full Year Financial Results delayed
AnnouncementREG - Arecor Therapeutics - BOARD CHANGE
AnnouncementREG - Arecor Therapeutics - Arecor and TRx Biosciences research collaboration
AnnouncementRCS - Arecor Therapeutics - Arecor and TRx Biosciences research collaboration
AnnouncementREG - Arecor Therapeutics - Arecor announces launch of Ogluo® in Netherlands
AnnouncementREG - Arecor Therapeutics - Year End Trading Update
AnnouncementREG - Arecor Therapeutics - Arecor announces update on INBRX-101
AnnouncementREG - Arecor Therapeutics - Arecor granted key European patent
AnnouncementREG - Arecor Therapeutics - Expansion of specialty hospital collaboration
AnnouncementREG - Arecor Therapeutics - Appointment of SVP for Tetris Pharma Ltd
AnnouncementREG - Arecor Therapeutics - Agreement with global medical products company
Announcement